Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy

Maturitas

Volumn 16, Issue 2, 1993, Pages 145-154

  Smith, Peter ^a   Heimer, Gun ^a   Lindskog, Marianne ^b   Ulmsten, Ulf ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Clinical Research Kabi Pharmacia AB ^*  (Sweden)

Author keywords

intravaginal ring; oestradiol; urogenital atrophy

Indexed keywords

ESTRADIOL; SILICONE;

ADULT; ARTICLE; CLIMACTERIUM; CONTROLLED STUDY; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; UROGENITAL SYSTEM; VAGINA ATROPHY;

ADMINISTRATION, INTRAVAGINAL; ADULT; AGED; ATROPHY; ESTRADIOL; FEMALE; HUMAN; MENOPAUSE; MIDDLE AGE; PESSARIES; SILICONES; SUPPORT, NON-U.S. GOV'T; UROGENITAL SYSTEM;

EID: 0027406245     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(93)90059-Q     Document Type: Article

References (26)

1. Research on the menopause
2. Current status of postmenopausal oestrogen therapy
3. Postmenopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50; the Framingham study
4. A review of study findings of the risks and benefits of oestrogen therapy in the female climacteric
5. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer
6. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study
7. Effects of vaginally-administered oestriol on post menopausal urogenital disorders: a cytohormonal study
8. Pharmacokinetics and pharmacodynamic effects of vaginal oestradiol administration from silastic rings in postmenopausal women
9. Development of a vaginal ring for achieving physiological levels of 17β-estradiol in hypoestrogenic women
10. Selecting constant serum estradiol levels achieved by vaginal rings
11. Endocrine impact of pure estradiol replacement in postmenopausal women: Alterations in anterior pituitary hormone release and circulating sex steroid hormone concentrations
12. Use of the progestagen challenge test to reduce the risk of endometrial cancer
13. A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens
14. Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women
15. Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy
16. Cytologic evaluation of the effect of various estrogens given in postmenopause
17. Determination of total oestrone in peripheral serum from non pregnant humans
18. Estrogen replacement and coronary artery disease
19. Postmenopausal estrogen therapy and cardiovascular disease
20. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence
21. Estrogen's role in endometrial cancer
22. The management of the pre-menopausal and the post-menopausal patient
23. Vaginal administration of low-dose oestradiol — effects on the endometrium and vaginal cytology
24. Endometrial morphology after 12 months of vaginal oestriol therapy in post-menopausal women
25. Vaginal administration of low-dose estradiol: safety and efficacy in long-term treatment of atrophic vaginitis